Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) was the target of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 31,870,000 shares, a growth of 28.7% from the September 30th total of 24,760,000 shares. Currently, 18.3% of the shares of the company are short sold. Based on an average daily volume of 9,830,000 shares, the short-interest ratio is currently 3.2 days.
Hims & Hers Health Trading Up 5.8 %
Shares of NYSE:HIMS traded up $1.26 during midday trading on Monday, hitting $22.99. 4,531,986 shares of the stock were exchanged, compared to its average volume of 8,168,695. The stock has a market cap of $4.94 billion, a P/E ratio of 287.41 and a beta of 1.06. Hims & Hers Health has a twelve month low of $5.65 and a twelve month high of $25.74. The company has a 50 day moving average price of $17.59 and a 200-day moving average price of $17.88.
Hims & Hers Health (NYSE:HIMS – Get Free Report) last announced its earnings results on Monday, August 5th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.02. Hims & Hers Health had a net margin of 1.70% and a return on equity of 5.25%. The firm had revenue of $315.65 million during the quarter, compared to the consensus estimate of $302.43 million. During the same quarter in the previous year, the company posted ($0.03) EPS. The firm’s revenue for the quarter was up 51.8% on a year-over-year basis. On average, equities research analysts expect that Hims & Hers Health will post 0.22 earnings per share for the current year.
Insider Activity
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in HIMS. Nisa Investment Advisors LLC grew its holdings in Hims & Hers Health by 679.2% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,839 shares of the company’s stock valued at $37,000 after buying an additional 1,603 shares during the period. Quest Partners LLC grew its holdings in Hims & Hers Health by 5,944.1% in the 2nd quarter. Quest Partners LLC now owns 3,566 shares of the company’s stock valued at $72,000 after buying an additional 3,507 shares during the period. CWM LLC grew its holdings in Hims & Hers Health by 21.4% in the 3rd quarter. CWM LLC now owns 5,982 shares of the company’s stock valued at $110,000 after buying an additional 1,054 shares during the period. Van ECK Associates Corp purchased a new stake in Hims & Hers Health in the 2nd quarter valued at about $111,000. Finally, Amalgamated Bank grew its holdings in Hims & Hers Health by 55.9% in the 2nd quarter. Amalgamated Bank now owns 6,566 shares of the company’s stock valued at $133,000 after buying an additional 2,354 shares during the period. Institutional investors and hedge funds own 63.52% of the company’s stock.
Analyst Ratings Changes
HIMS has been the subject of several analyst reports. Bank of America upped their price objective on Hims & Hers Health from $23.00 to $25.00 and gave the company a “buy” rating in a research note on Monday, October 21st. Imperial Capital downgraded Hims & Hers Health from an “outperform” rating to an “in-line” rating in a research note on Friday, August 9th. TD Cowen boosted their target price on Hims & Hers Health from $15.00 to $25.00 and gave the stock a “buy” rating in a research report on Thursday, July 11th. Needham & Company LLC assumed coverage on Hims & Hers Health in a report on Thursday, August 22nd. They issued a “buy” rating and a $24.00 price target for the company. Finally, Piper Sandler reiterated a “neutral” rating and issued a $18.00 price objective on shares of Hims & Hers Health in a research report on Tuesday, August 6th. Eight investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $20.21.
Get Our Latest Research Report on HIMS
Hims & Hers Health Company Profile
Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
Recommended Stories
- Five stocks we like better than Hims & Hers Health
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Inflation Risk Rising, Key Trades Investors Are Making Now
- 3 Best Fintech Stocks for a Portfolio Boost
- 3 Oil Stocks to Watch Before Earnings Come Out
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.